MannKind Corp. (MNKD)
5.425
+0.22
(+4.13%)
USD |
NASDAQ |
Jan 20, 14:43
MannKind EPS Diluted (Quarterly): 0.0256 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 0.0558 |
| Keros Therapeutics, Inc. | -0.1792 |
| Moderna, Inc. | -0.5128 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| TG Therapeutics, Inc. | 2.428 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.985M |
| Revenue (Quarterly) | 82.13M |
| Total Expenses (Quarterly) | 74.14M |
| Enterprise Value | 1.566B |
| Gross Profit Margin (Quarterly) | 75.40% |
| Profit Margin (Quarterly) | 9.72% |
| Earnings Yield | 1.74% |
| Operating Earnings Yield | 4.56% |
| Normalized Earnings Yield | 2.597 |